Targeting apoptosis in cancer therapy

BA Carneiro, WS El-Deiry - Nature reviews Clinical oncology, 2020 - nature.com
For over three decades, a mainstay and goal of clinical oncology has been the development
of therapies promoting the effective elimination of cancer cells by apoptosis. This …

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

BJ Aubrey, GL Kelly, A Janic, MJ Herold… - Cell death & …, 2018 - nature.com
The tumour suppressor gene TP53 is mutated in~ 50% of human cancers. In addition to its
function in tumour suppression, p53 also plays a major role in the response of malignant as …

[HTML][HTML] Cell death in the origin and treatment of cancer

A Strasser, DL Vaux - Molecular cell, 2020 - cell.com
Cell death, or, more specifically, cell suicide, is a process of fundamental importance to
human health. Throughout our lives, over a million cells are produced every second. When …

Should mutant TP53 be targeted for cancer therapy?

Z Wang, A Strasser, GL Kelly - Cell Death & Differentiation, 2022 - nature.com
Mutations in the TP53 tumour suppressor gene are found in~ 50% of human cancers [,,,,–].
TP53 functions as a transcription factor that directly regulates the expression of~ 500 genes …

Cell death signaling

DR Green, F Llambi - Cold Spring Harbor perspectives …, 2015 - cshperspectives.cshlp.org
In multicellular organisms, cell death is a critical and active process that maintains tissue
homeostasis and eliminates potentially harmful cells. There are three major types of …

BCL-2 protein family: attractive targets for cancer therapy

D Kaloni, ST Diepstraten, A Strasser, GL Kelly - Apoptosis, 2023 - Springer
Acquired resistance to cell death is a hallmark of cancer. The BCL-2 protein family members
play important roles in controlling apoptotic cell death. Abnormal over-expression of pro …

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

PE Czabotar, G Lessene, A Strasser… - Nature reviews Molecular …, 2014 - nature.com
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell
suicide programme that is essential for development, tissue homeostasis and immunity. Too …

BH3-mimetic drugs: blazing the trail for new cancer medicines

D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts… - Cancer cell, 2018 - cell.com
Defects in apoptotic cell death can promote cancer and impair responses of malignant cells
to anti-cancer therapy. Pro-survival BCL-2 proteins prevent apoptosis by kee** the cell …

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

AF Thomas, GL Kelly, A Strasser - Cell Death & Differentiation, 2022 - nature.com
The tumour suppressor TP53 is a master regulator of several cellular processes that
collectively suppress tumorigenesis. The TP53 gene is mutated in~ 50% of human cancers …

The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics

AN Hata, JA Engelman, AC Faber - Cancer discovery, 2015 - AACR
The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2
family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic …